tiprankstipranks
Alphatec (ATEC)
NASDAQ:ATEC
US Market
Want to see ATEC full AI Analyst Report?

Alphatec Holdings (ATEC) Earnings Dates, Call Summary & Reports

952 Followers

Earnings Data

Report Date
Jul 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.07
Last Year’s EPS
0.02
Same Quarter Last Year
Based on 11 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a largely constructive operational and financial picture: healthy top-line growth (14% total, 17% surgical), strong surgeon and case adoption (23% and 21%), margin expansion, and substantial adjusted EBITDA improvement (97% YoY). Key near-term execution challenges center on EOS system deliveries and installation timing, mix-driven revenue-per-case pressure, and temporary working-capital investments (inventory/instruments). Management updated EOS near-term expectations but maintained surgical and adjusted EBITDA guidance, emphasized corrective actions (sales/marketing/support hires), and closed a favorable refinancing to improve the capital structure. On balance, the positive scale, profitability, and strategic momentum outweigh the execution-related headwinds noted for the quarter.
Company Guidance
Management reiterated full‑year 2026 guidance for total revenue of about $882M (≈15% YoY) with surgical revenue ~ $805M (≈17% YoY, +$118M) and EOS revenue ~ $77M; Q1 actuals were $192M (+14% YoY) with surgical $178M (+17%), cases +21%, new surgeons +23%, revenue per case down ~3% YoY, EOS Q1 $14M (‑$3M YoY) while global EOS units +7% YoY, U.S. EOS Edge +39% and EOS Insight accounts >2x; margins and cash metrics showed gross margin 71.6% (+120 bps), adj. EBITDA Q1 $21M (11% of revenue, +97% YoY) with 45% drop‑through on incremental revenue and FY adj. EBITDA guidance of ~$134M (15% margin, ~35% drop‑through), free cash flow at least $20M (Q2 ~0), ending cash ≈$140M after ~$11M cash used in Q1 and ~$33M invested in inventory/instruments, plus a new credit facility at SOFR+275 bps maturing May 2031 expected to reduce interest >$6M/year and save up to ~$35M over its life.
Top-line Revenue Growth
Total Q1 revenue of $192M, up 14% year over year; surgical revenue $178M, up 17% year over year.
Strong Procedural and Surgeon Adoption
Cases increased 21% year over year and new surgeon users grew 23% year over year, indicating durable adoption and volume-led growth.
Adjusted EBITDA and Profitability Expansion
Adjusted EBITDA of $21M in Q1 (11% of revenue), up 97% year over year; company reports ~45% drop-through on incremental revenue and trailing twelve-month EBITDA now >$100M.
Gross Margin and Operating Leverage
Gross margin 71.6%, improved by over 120 basis points year over year; operating expenses grew ~6% year over year, below revenue growth, demonstrating operating leverage.
Procedure-Level ASP Strength
Core procedural ASPs showed strength: lateral +2% YoY, ALIF +4% YoY, cervical +8% YoY.
Cash Position and Cash Flow
Ending cash approximately $140M; positive operating cash flow for the fourth consecutive quarter; free cash used ~$11M in Q1 (within expected range) and full-year free cash flow guidance of at least $20M.
Strategic Financing Improvement
Closed new Term Loan A and revolving credit facility that extends maturities to 2031, reduces interest expense by >$6M annually and is estimated to save up to ~$35M in interest over the facility life (rate SOFR + 275 bps).
EOS Platform Traction and Installed Base Growth
Installed base of global EOS units increased 7% YoY; EOS Edge installed base grew 39% YoY; EOS Insight accounts more than doubled and EOS Insight adoption shows meaningful implant pull-through and ~30% revenue lift per surgeon after adoption.

Alphatec Holdings (ATEC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ATEC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
0.07 / -
0.02
May 05, 2026
2026 (Q1)
-0.02 / 0.00
-0.112
Feb 24, 2026
2025 (Q4)
0.04 / 0.06
-0.034276.47% (+0.09)
Oct 30, 2025
2025 (Q3)
-0.03 / 0.03
-0.108127.78% (+0.14)
Jul 31, 2025
2025 (Q2)
-0.04 / 0.02
-0.143113.99% (+0.16)
May 01, 2025
2025 (Q1)
-0.12 / -0.11
-0.18138.12% (+0.07)
Feb 26, 2025
2024 (Q4)
-0.05 / -0.03
-0.11169.37% (+0.08)
Oct 30, 2024
2024 (Q3)
-0.11 / -0.11
-0.14123.40% (+0.03)
Jul 31, 2024
2024 (Q2)
-0.12 / -0.14
-0.113-26.55% (-0.03)
May 07, 2024
2024 (Q1)
-0.15 / -0.18
-0.17-6.47% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ATEC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 05, 2026
$10.23$6.99-31.67%
Feb 24, 2026
$13.93$14.04+0.79%
Oct 30, 2025
$16.33$18.99+16.29%
Jul 31, 2025
$10.58$13.77+30.15%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alphatec (ATEC) report earnings?
Alphatec (ATEC) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
    What is Alphatec (ATEC) earnings time?
    Alphatec (ATEC) earnings time is at Jul 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ATEC EPS forecast?
          ATEC EPS forecast for the fiscal quarter 2026 (Q2) is 0.07.